Genetic Technologies, Inc.

Genetic Technologies, Inc. is a leading DNA forensic science company established in 1998. The company offers comprehensive and accredited services in the testing and evaluation of forensic evidence for human identification. Catering to a diverse and expanding client base that includes private individuals, investigators, law enforcement agencies, public defenders, criminal defense attorneys, and prosecutors, Genetic Technologies, Inc. specializes in a wide array of forensic biology technologies. These include DNA analysis (Autosomal and Y-STRs), touch DNA (Low Copy Analysis), Crime Scene Investigation (CSI), serology, and expert witness and consulting services for both civil investigations and criminal cases. The last investment in the company was a Private Equity Round investment on 27 August 2013. As of now, information regarding the specific investors and the headquarters location is not available. The industries Genetic Technologies, Inc. operates within include Biotechnology, Information Technology, and Life Sciences.